That doesn't suggest they are not contemplating it. Quite a few breakthrough therapy designations have been granted for psilocybin while in the treatment of resistant depression—that's, depression that does not respond to at the least two differing types of antidepressants—in addition to a broader approval could be about the horizon.Members who